Tern plc CEO Al Sisto says “…very exciting times for Wyld Networks”

Tern - Wyld Networks

Tern Plc (LON:TERN), the company focused on value creation from Internet of Things technology businesses, has noted that Wyld Networks AB has announced an equity fundraising of approximately SEK 7.3 million (approximately £0.58 million), before transaction costs. Wyld Networks’ shares are traded on the Nasdaq First North Growth Market in Stockholm and the Fundraise price of 12.03 SEK per Wyld Networks share is at a 12.5% discount to the five-day volume weighted average price of Wyld Networks’ shares from 31 October to 4 November 2022.

Wyld Networks has undertaken the Fundraise with certain strategic and long-term investors to provide the business with additional capital to further expand its operations in order to meet the growing demand and to accelerate its growth.  Wyld Networks intends to use the proceeds from the Fundraise to strengthen its commercial team in order to accelerate the conversion of launch partners into paying customers and to invest in its development team to maintain competitive advantage and execute on its product roadmap. Neither Tern nor any of its directors have participated in the Fundraise.

Following the Fundraise, Tern’s holding in Wyld Networks’ equity of 5,171,425 Wyld Networks shares will reduce from 49.2% to approximately 46.5%.

Commenting Al Sisto, CEO of Tern plc, said“These are very exciting times for Wyld Networks as it continues to build the business ahead of the expected launch of its commercial sensor-to-satellite service in December 2022.  Tern is very supportive of Wyld Networks using their NASDAQ First North quote and the directed share issue process to access the growth capital they require, whilst enabling Tern to maintain a very significant holding as their largest shareholder.  We look forward to reporting on Wyld Networks’ further progress in due course.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Device Authority targets cyber resilience opportunity at TechWorks Summit 2026

Device Authority will focus on continuous IoT and OT compliance, AI and quantum risk at TechWorks Summit 2026 as it strengthens its position in connected-device security.

Talking Medicines builds a more defensible AI model for life sciences

Talking Medicines is combining proprietary healthcare intelligence, AI agents and orchestration to build a more specialised AI platform for life sciences.

Fundamental XR builds case for wider surgical simulation adoption

Fundamental XR is expanding the role of virtual simulation in surgical training as hospitals integrate the technology into structured education programmes.

Device Authority strengthens position in machine identity and Zero Trust Security

Device Authority’s inclusion in two 2026 Gartner Hype Cycle reports reinforces its positioning in machine identity, IoT authentication and Zero Trust security.

Talking Medicines highlights strategic value of patient journey intelligence

Patient journey intelligence can help healthcare organisations identify care barriers and design more responsive pathways around real patient experiences.

Evidence-based care pathways support more consistent healthcare delivery

Evidence-based care pathways can improve diagnosis, treatment consistency and the integration of new therapies into routine care.

Search